PPARGC1A and hydrops fetalis: Our primary focus encompassed the evaluation of the protective effects of GRb1@PLGA@NPs against myocardial injury, with a dedicated exploration of the potential mechanisms underpinning GRb1@PLGA@NPs’ therapeutic efficacy through the ROS/PPARα/PGC1α pathway, thereby orchestrating the energy metabolism to mitigate HF.